LAUSR

Skin cancer is one of the leading causes of skin disease burden worldwide. This systematic review provides an overview of the United States (US) and global melanoma and non-melanoma skin cancer (NMSC) epidemiologic studies published in the last 5 years. The incidence of melanoma and NMSC continues to rise both in the US and worldwide. The highest global age-standardized incidence rates (ASIRs) for melanoma were Australasia, North America, Eastern Europe, Western Europe, and Central Europe. Various results were reported for the mortality of skin cancer; however, overall, the mortality was higher in men than women and remained relatively stable. Notably, NMSC caused more deaths globally than melanoma, albeit at a slower rate. Epidemiologic studies on skin cancer provide the vital information needed to implement effective preventive efforts. Increased global skin cancer burden necessitates continued surveillance and production of accurate, high-quality NMSC and melanoma epidemiologic studies.